Early research (Phase 1)Study completedNCT02857868
What this trial is testing
A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects
Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 32
Showing 20 of 0 results